Johnny Kao

Summary

Affiliation: University of Chicago
Country: USA

Publications

  1. ncbi request reprint Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review
    Johnny Kao
    Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL 60637, USA
    Cancer Treat Rev 29:21-30. 2003
  2. ncbi request reprint Is there an association between multiple myeloma and prostate cancer?
    Johnny Kao
    Department of Radiation and Cellular Oncology, University of Chicago, 5758 South Maryland Avenue, MC 9006, Chicago, IL 60637, USA
    Med Hypotheses 63:226-31. 2004
  3. ncbi request reprint Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma
    Joseph K Salama
    Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, Chicago, IL 60637 1470, USA
    Int J Radiat Oncol Biol Phys 64:382-91. 2006
  4. ncbi request reprint Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions
    Michael T Milano
    Department of Cellular and Radiation Oncology, University of Chicago, Chicago, IL 60637, USA
    Int J Oncol 28:1141-51. 2006
  5. ncbi request reprint Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy
    Michael T Milano
    Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, 5841 S Maryland Ave, MC 9006, Chicago, IL 60637, USA
    Int J Radiat Oncol Biol Phys 61:1096-106. 2005
  6. ncbi request reprint Hormone therapy and radiotherapy for early prostate cancer: a utility-adjusted number needed to treat (NNT) analysis
    Ashesh B Jani
    Department of Radiation and Cellular Oncology, University of Chicago, 5758 S Maryland Avenue, MC 9001, Chicago, IL 60637, USA
    Int J Radiat Oncol Biol Phys 61:687-94. 2005
  7. ncbi request reprint Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: results from two consecutive phase I/II trials
    Johnny Kao
    Department of Radiation and Cellular Oncology, University of Chicago and Pritzker School of Medicine, Chicago, IL, USA
    Int J Radiat Oncol Biol Phys 61:1045-53. 2005
  8. ncbi request reprint Postprostatectomy adjuvant versus salvage radiotherapy: a complication-adjusted number-needed-to-treat analysis
    Ashesh B Jani
    Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, Illinois 60637, USA
    Cancer 103:1833-42. 2005
  9. ncbi request reprint Hormone therapy adjuvant to external beam radiotherapy for locally advanced prostate carcinoma: a complication-adjusted number-needed-to-treat analysis
    Ashesh B Jani
    Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois 60637, USA
    Cancer 98:2351-61. 2003
  10. ncbi request reprint Does the number of lymph nodes examined in patients with lymph node-negative breast carcinoma have prognostic significance?
    Joseph K Salama
    Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois 60637, USA
    Cancer 103:664-71. 2005

Detail Information

Publications16

  1. ncbi request reprint Reirradiation of recurrent and second primary head and neck malignancies: a comprehensive review
    Johnny Kao
    Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL 60637, USA
    Cancer Treat Rev 29:21-30. 2003
    ..The results of reirradiation in recurrent head and neck cancer and the prognostic factors predicting outcome in this patient population are reviewed...
  2. ncbi request reprint Is there an association between multiple myeloma and prostate cancer?
    Johnny Kao
    Department of Radiation and Cellular Oncology, University of Chicago, 5758 South Maryland Avenue, MC 9006, Chicago, IL 60637, USA
    Med Hypotheses 63:226-31. 2004
    ....
  3. ncbi request reprint Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma
    Joseph K Salama
    Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, Chicago, IL 60637 1470, USA
    Int J Radiat Oncol Biol Phys 64:382-91. 2006
    ....
  4. ncbi request reprint Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions
    Michael T Milano
    Department of Cellular and Radiation Oncology, University of Chicago, Chicago, IL 60637, USA
    Int J Oncol 28:1141-51. 2006
    ..Building on the present clinical experience, future directions include more directed efforts at reducing toxicity, with better planning software and planning techniques...
  5. ncbi request reprint Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy
    Michael T Milano
    Department of Radiation and Cellular Oncology, University of Chicago Pritzker School of Medicine, 5841 S Maryland Ave, MC 9006, Chicago, IL 60637, USA
    Int J Radiat Oncol Biol Phys 61:1096-106. 2005
    ..5-Gy) radiotherapy delivered on alternating weeks (TFGX(2)) in locally advanced head-and-neck cancer. Here, we report the clinical outcome and late toxicity of TFGX(2) in a subset of patients previously irradiated to the head and neck...
  6. ncbi request reprint Hormone therapy and radiotherapy for early prostate cancer: a utility-adjusted number needed to treat (NNT) analysis
    Ashesh B Jani
    Department of Radiation and Cellular Oncology, University of Chicago, 5758 S Maryland Avenue, MC 9001, Chicago, IL 60637, USA
    Int J Radiat Oncol Biol Phys 61:687-94. 2005
    ..To quantify, using the number needed to treat (NNT) methodology, the benefit of short-term (< or =6 months) hormone therapy adjuvant to radiotherapy in the group of patients with early (clinical stage T1-T2c) prostate cancer...
  7. ncbi request reprint Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: results from two consecutive phase I/II trials
    Johnny Kao
    Department of Radiation and Cellular Oncology, University of Chicago and Pritzker School of Medicine, Chicago, IL, USA
    Int J Radiat Oncol Biol Phys 61:1045-53. 2005
    ..This analysis focuses on rates of locoregional control and radiation-associated acute and late complications...
  8. ncbi request reprint Postprostatectomy adjuvant versus salvage radiotherapy: a complication-adjusted number-needed-to-treat analysis
    Ashesh B Jani
    Department of Radiation and Cellular Oncology, University of Chicago Hospitals, Chicago, Illinois 60637, USA
    Cancer 103:1833-42. 2005
    ..The purpose of the current investigation was to systematically compare adjuvant versus salvage RT in a manner that incorporates both treatment efficacy and complications...
  9. ncbi request reprint Hormone therapy adjuvant to external beam radiotherapy for locally advanced prostate carcinoma: a complication-adjusted number-needed-to-treat analysis
    Ashesh B Jani
    Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois 60637, USA
    Cancer 98:2351-61. 2003
    ....
  10. ncbi request reprint Does the number of lymph nodes examined in patients with lymph node-negative breast carcinoma have prognostic significance?
    Joseph K Salama
    Department of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois 60637, USA
    Cancer 103:664-71. 2005
    ..Therefore, the authors analyzed the impact of the number of tumor-free axillary lymph nodes on disease-free survival (DFS) in two distinct patient populations...
  11. doi request reprint Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage
    Johnny Kao
    Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA
    Int J Radiat Oncol Biol Phys 71:362-70. 2008
    ..The impact of RT on survival for various subgroups of node-positive HNSCC has not been clearly demonstrated...
  12. ncbi request reprint Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma
    Amir Lavaf
    Department of Radiation Oncology, Mount Sinai School of Medicine, New York, New York 10029, USA
    Cancer 112:535-43. 2008
    ..In the current study, the frequency and effect of adjuvant RT on overall survival was investigated in patients with resected lymph node-positive head and neck cancer...
  13. ncbi request reprint (125)I monotherapy using D90 implant doses of 180 Gy or greater
    Johnny Kao
    Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA
    Int J Radiat Oncol Biol Phys 70:96-101. 2008
    ..The purpose of this study was to characterize the oncologic results and toxicity profile of patients treated with (125)I implants using the dose delivered to 90% of the gland from the dose-volume histogram (D90) of greater than 144 Gy...
  14. ncbi request reprint In response to Dr. Formenti et al. (Int J Radiat Oncol Biol Phys 2005, 63:1275-1276)
    Johnny Kao
    Int J Radiat Oncol Biol Phys 64:658. 2006
  15. ncbi request reprint Effect of low dose-rate prostate brachytherapy on the sexual health of men with optimal sexual function before treatment: analysis at > or = 7 years of follow-up
    Jamie A Cesaretti
    Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA
    BJU Int 100:362-7. 2007
    ..To evaluate the effect of low-dose rate prostate brachytherapy on the sexual health of men with > or = 7 years of prospective evaluation and optimum sexual function before treatment...
  16. doi request reprint Correlation of positron emission tomography standard uptake value and pathologic specimen size in cancer of the head and neck
    Ryan J Burri
    Department of Radiation Oncology, Mount Sinai School of Medicine, New York, NY 10029, USA
    Int J Radiat Oncol Biol Phys 71:682-8. 2008
    ..To correlate positron emission tomography (PET) standard uptake value (SUV) with pathologic specimen size in patients with head-and-neck cancers...